Uterine Fibroid Management
Diagnosis and Imaging
- The American College of Radiology recommends transvaginal ultrasound (TVUS) combined with transabdominal ultrasound (TAUS) as the preferred initial imaging modality for fibroid evaluation, with 90-99% sensitivity for detecting uterine fibroids and 90% sensitivity and 98% specificity for submucosal fibroids 1
- Doppler imaging should be included as a standard component to evaluate internal fibroid vascularity, growth potential, and differentiation between vascular and nonvascular tissue 1
- Saline infusion sonohysterography (SIS) is recommended when submucosal fibroids are suspected to better delineate between endometrial pathologies and submucosal fibroids and accurately depict the percentage of intracavitary component of submucosal fibroids 1
- MRI with contrast is indicated when multiple fibroids are present, precise mapping is needed for surgical planning, or ultrasound findings are inconclusive 1
- Pelvic ultrasound (transabdominal and transvaginal) is the preferred initial and follow-up imaging modality for monitoring fibroid growth, and rapid growth of fibroids should prompt further evaluation to rule out malignancy, especially in postmenopausal women 1, 2
Treatment Options
- Selective progesterone receptor modulators (SPRMs) are recommended for bleeding control in patients with uterine fibroids, according to the American Journal of Obstetrics and Gynecology 3
- First-line treatments for bleeding symptoms include NSAIDs, hormonal contraceptives, tranexamic acid, and progestin-containing IUDs, as recommended by the American College of Radiology 2
- Hormonal contraceptives are an effective option for managing bleeding symptoms, especially with small fibroids, according to the American College of Radiology 4
- GnRH agonists, such as leuprolide acetate, reduce fibroid size by 40-50% and are effective for controlling bleeding, but are a temporary solution due to hypoestrogenic side effects 2, 4, 5
- Mifepristone, a selective progesterone receptor modulator, shows promising results in reducing leiomyoma volume and menstrual blood loss, but needs more long-term studies 4
- Uterine Artery Embolization (UAE) is effective when excessive bleeding is unacceptable or patient declines surgery, with shorter hospital stay and recovery time compared to surgery, but has higher reintervention rates (36%) compared to myomectomy (5%) 4, 5
- UAE is not recommended for women desiring future pregnancy due to higher pregnancy complications 4
Surgical Treatment Options
- Hysterectomy is considered the "gold standard" treatment with virtually zero recurrence risk, and provides significantly better health-related quality-of-life outcomes compared to other treatments, according to the American College of Radiology and Environmental Health Perspectives 4, 5
- Hysterectomy can be performed via abdominal, vaginal, or laparoscopic approaches, and eliminates reproductive potential 5
- Myomectomy is preferred for women desiring future fertility, and can be performed abdominally, laparoscopically, or hysteroscopically depending on fibroid location, with recurrence rates ranging from 23-33% 4, 5
- Hysteroscopic myomectomy is the most cost-effective method for completely intracavitary fibroids, suitable for submucosal fibroids with significant protrusion into the endometrial cavity 5
- Laparoscopic uterine artery occlusion (LUAO) and High-intensity focused ultrasound (HIFU) are other techniques available, according to the American College of Radiology 4
Fertility and Malignancy Considerations
- Submucosal fibroids have the greatest impact on fertility, and removal may improve conception rates by 54-59%, according to Environmental Health Perspectives 5
- Though rare (0.5% of presumed fibroids), rapid growth or irregular appearance should prompt evaluation for leiomyosarcoma, highlighting the importance of accurate diagnosis and monitoring 3
- Submucosal fibroids cause the most bleeding and respond well to hysteroscopic removal, while intramural fibroids may affect implantation rates in women trying to conceive 5
- GnRH agonists may make small intramural fibroids difficult to palpate during myomectomy, potentially leading to incomplete removal and apparent "rapid recurrence" 5
- Hysterectomy is the definitive treatment for symptomatic calcified leiomyomas in women who do not desire future fertility, offering complete symptom resolution and elimination of recurrence risk, with satisfaction rates exceeding 90% 5
Follow-up and Monitoring
- Follow-up ultrasound is recommended at 3 months post-treatment and 12 months post-treatment to assess uterine volume, fibroid volume, fibroid location, and vascularity (using Doppler) 1
- Warning signs requiring immediate evaluation include rapid increase in fibroid size, irregular appearance on ultrasound, and new onset of symptoms in previously asymptomatic fibroids, as reported by the American Journal of Obstetrics and Gynecology 3
- The American College of Radiology recommends determining if the fibroid is causing symptoms such as heavy menstrual bleeding, pelvic pressure or pain, urinary frequency or urgency, constipation or bowel dysfunction, or dyspareunia (painful intercourse) before considering treatment 2
- Small asymptomatic fibroids (e.g., 7mm) rarely warrant intervention and can be monitored with periodic ultrasound, as most fibroids of this size are asymptomatic and do not require active intervention 2
- Rapid growth or irregular appearance of fibroids should prompt evaluation for leiomyosarcoma, although malignancy risk is rare (0.5% of presumed fibroids), as stated by the American College of Radiology 4